{"title":"Design, synthesis, and anticancer evaluation of novel coumarin/thiazole congeners as potential CDK2 inhibitors with molecular dynamics","link":"http://pubs.rsc.org/en/Content/ArticleLanding/2024/RA/D4RA02456G","date":null,"content":"<div><p><img src=\"/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D4RA02456G\" /></p></div><div><i><b>RSC Adv.</b></i>, 2024, <b>14</b>,18838-18855<br /><b>DOI</b>: 10.1039/D4RA02456G, Paper</div><div><img alt=\"Open Access\" src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png\" /> Open Access</div><div><a href=\"http://creativecommons.org/licenses/by-nc/3.0/\" target=\"_blank\"> <img src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png\" alt=\"Creative Commons Licence\" /></a>  This article is licensed under a <a href=\"http://creativecommons.org/licenses/by-nc/3.0/\" target=\"_blank\">Creative Commons Attribution-NonCommercial 3.0 Unported Licence.</a></div><div>Samir Bondock, Nada Alabbad, Aisha Hossan, Moaz M. Abdou, Ali A. Shati, Mohammad Y. Alfaifi, Serag E. I. Elbehairi, Nada M. Mohamed<br />A series of novel coumarin–thiazoles was designed and synthesized as a possible CDK2 inhibitor with anticancer activity with low toxicity.<br />The content of this RSS Feed (c) The Royal Society of Chemistry</div>","author":"","siteTitle":"RSC - RSC Adv. latest articles","siteHash":"da3e282678330308414c63a405ade89dd3738fcce2936ca8a2fe3a6d7e967d99","entryHash":"5d414f45a89bbeb612be76906c6478268bae40d02d1248373e4cdf8667efdc89","category":"Environment"}